Monsenso AS (MONSO) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.309x

Based on the latest financial reports, Monsenso AS (MONSO) has a cash flow conversion efficiency ratio of -0.309x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-2.16 Million ≈ $-337.32K USD) by net assets (Dkr6.98 Million ≈ $1.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Monsenso AS fund operations to measure how many days the company can operate on defensive assets alone.

Monsenso AS - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Monsenso AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Monsenso AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Monsenso AS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
C&C Group plc
LSE:CCR
0.072x
Fairchild Gold Corp
V:FAIR
-0.117x
NanoVibronix Inc
NASDAQ:NAOV
-0.046x
Mustang Bio Inc
NASDAQ:MBIO
-0.117x
The GYM Group PLC
LSE:GYM
0.318x
IDOX plc
LSE:IDOX
0.002x
ACRUX Ltd
AU:ACR
-3.930x
Simble Solutions Ltd
AU:SIS
1.447x

Annual Cash Flow Conversion Efficiency for Monsenso AS (2016–2025)

The table below shows the annual cash flow conversion efficiency of Monsenso AS from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Monsenso AS.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Dkr6.98 Million
≈ $1.09 Million
Dkr-1.49 Million
≈ $-233.12K
-0.214x +56.98%
2024-12-31 Dkr14.16 Million
≈ $2.22 Million
Dkr-7.03 Million
≈ $-1.10 Million
-0.497x -311.56%
2023-12-31 Dkr10.87 Million
≈ $1.70 Million
Dkr2.55 Million
≈ $399.28K
0.235x +202.16%
2022-12-31 Dkr14.76 Million
≈ $2.31 Million
Dkr-3.39 Million
≈ $-530.39K
-0.230x -12.40%
2021-12-31 Dkr21.44 Million
≈ $3.35 Million
Dkr-4.38 Million
≈ $-685.75K
-0.204x -231.21%
2020-12-31 Dkr18.65 Million
≈ $2.92 Million
Dkr2.91 Million
≈ $454.66K
0.156x +386.64%
2019-12-31 Dkr3.86 Million
≈ $604.55K
Dkr-210.00K
≈ $-32.86K
-0.054x +91.70%
2018-12-31 Dkr3.82 Million
≈ $597.20K
Dkr-2.50 Million
≈ $-390.99K
-0.655x -28.52%
2017-12-31 Dkr4.91 Million
≈ $767.42K
Dkr-2.50 Million
≈ $-390.94K
-0.509x -32.62%
2016-12-31 Dkr6.51 Million
≈ $1.02 Million
Dkr-2.50 Million
≈ $-390.94K
-0.384x --

About Monsenso AS

CO:MONSO Denmark Health Information Services
Market Cap
$4.37 Million
Dkr27.91 Million DKK
Market Cap Rank
#28804 Global
#138 in Denmark
Share Price
Dkr0.42
Change (1 day)
-9.52%
52-Week Range
Dkr0.10 - Dkr0.46
All Time High
Dkr23.50
About

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution,… Read more